Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| §102 only | 1 (25%) |
| §112 only | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHANDRAKUMAR, NIZAL S | 1 | 72.6% | +18.2% |
| HEASLEY, MEGHAN CHRISTINE | 1 | 76.5% | +35.6% |
| ALLEN, SARAH ELIZABETH | 1 | 61.9% | +44.4% |
| ROBINSON, MIKHAIL O'DONNEL | 1 | 56.8% | +41.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18546800 | HEMI-CITRATE SALTS OF GABA-A POSITIVE ALLOSTERIC MODULATOR AND CRYSTALLINE FORM THEREOF | CHANDRAKUMAR, NIZAL S | 22d |
| 17906893 | KCNT1 INHIBITORS AND METHODS OF USE | ROBINSON, MIKHAIL O'DONNEL | 22d |
| 18258418 | KCNT1 INHIBITORS AND METHODS OF USE | HEASLEY, MEGHAN CHRISTINE | 71d |
| 18005800 | COMPOSITIONS AND METHODS FOR TREATING DISORDERS ASSOCIATED WITH LOSS-OF-FUNCTION MUTATIONS IN SCN2A | ALLEN, SARAH ELIZABETH | 83d |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1626 | 1 |
| 1637 | 1 |
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18546800 | HEMI-CITRATE SALTS OF GABA-A POSITIVE ALLOSTERIC MODULATOR AND CRYSTALLINE FORM THEREOF | CHANDRAKUMAR, NIZAL S | 1625 | §112 | Non-Final OA | 22d | Pending | Aug 17, 2023 |
| 18258418 | KCNT1 INHIBITORS AND METHODS OF USE | HEASLEY, MEGHAN CHRISTINE | 1626 | §102 | Final Rejection | 71d | Pending | Jun 20, 2023 |
| 18005800 | COMPOSITIONS AND METHODS FOR TREATING DISORDERS ASSOCIATED WITH LOSS-OF-FUNCTION MUTATIONS IN SCN2A | ALLEN, SARAH ELIZABETH | 1637 | §103 | Non-Final OA | 83d | Pending | Jan 17, 2023 |
| 17906893 | KCNT1 INHIBITORS AND METHODS OF USE | ROBINSON, MIKHAIL O'DONNEL | 1627 | §103 | Non-Final OA | 22d | Pending | Sep 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial